Clinical study of PLN-101325

Status: Not yet recruiting

Phase of Trial: Phase I

Latest Information Update: 10 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

06 May 2024 According to a Pliant Therapeutics media release, the Company recently received regulatory clearance from Australias Research Ethics Committee (HREC) for the conduct of a first-in-human Phase 1 clinical study of PLN-101325
06 May 2024 Status changed from planning to not yet recruiting as per Pliant Therapeutics media release.
09 Aug 2023 According to a Pliant Therapeutics media release, an IND submission for PLN-101325 for Duchenne muscular dystrophy (DMD) is expected in the first quarter of 2024.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com